Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

MNOV – Medicinova Inc

MediciNova, Inc.
MNOV
$1.24
Name : MediciNova, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $60,817,288.00
EPSttm : -0.23
finviz dynamic chart for MNOV
MediciNova, Inc.
$1.24
7.46%
$0.1

Float Short %

0.52

Margin Of Safety %

Put/Call OI Ratio

0.16

EPS Next Q Diff

-0.06

EPS Last/This Y

-0.27

EPS This/Next Y

0.12

Price

1.25

Target Price

7.5

Analyst Recom

1

Performance Q

-41.78

Relative Volume

2.76

Beta

0.49

Ticker: MNOV




23 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-03-05MNOV1.650.16999.99424
2025-03-06MNOV1.5650.16999.99424
2025-03-07MNOV1.570.16999.99424
2025-03-10MNOV1.490.16999.99424
2025-03-11MNOV1.450.160.00424
2025-03-12MNOV1.4640.160.00424
2025-03-13MNOV1.470.140.00464
2025-03-14MNOV1.540.140.00464
2025-03-17MNOV1.540.140.00464
2025-03-18MNOV1.530.140.00464
2025-03-19MNOV1.530.140.00464
2025-03-20MNOV1.520.140.00472
2025-03-21MNOV1.530.140.00474
2025-03-24MNOV1.50.170.00391
2025-03-25MNOV1.48490.170.00391
2025-03-26MNOV1.4730.170.00391
2025-03-27MNOV1.490.170.00391
2025-03-28MNOV1.460.170.00391
2025-03-31MNOV1.470.170.00391
2025-04-01MNOV1.460.170.00392
2025-04-02MNOV1.450.170.00392
2025-04-03MNOV1.330.170.00392
2025-04-04MNOV1.260.160.00412
DateSymbolLastP/C OIP/C VolTotal OI
23 items Current Page1 of 1




23 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-03-05MNOV1.64- - -0.50
2025-03-06MNOV1.58- - -0.50
2025-03-07MNOV1.59- - -0.50
2025-03-10MNOV1.49- - -0.50
2025-03-11MNOV1.44- - -0.50
2025-03-12MNOV1.50- - -0.50
2025-03-13MNOV1.47- - -0.50
2025-03-14MNOV1.55- - -0.50
2025-03-17MNOV1.54- - -0.50
2025-03-18MNOV1.50- - -0.50
2025-03-19MNOV1.55- - -0.50
2025-03-20MNOV1.51- - -0.50
2025-03-21MNOV1.52- - -0.50
2025-03-24MNOV1.49- - -0.50
2025-03-25MNOV1.47- - -0.50
2025-03-26MNOV1.47- - -0.50
2025-03-27MNOV1.46- - -0.50
2025-03-28MNOV1.45- - -0.50
2025-03-31MNOV1.46- - -0.50
2025-04-01MNOV1.45- - -0.50
2025-04-02MNOV1.41- - -0.50
2025-04-03MNOV1.34- - -0.50
2025-04-04MNOV1.25- - -0.50
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
23 items Current Page1 of 1




23 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-03-05MNOV0.006.100.65
2025-03-06MNOV0.006.100.65
2025-03-07MNOV0.006.100.65
2025-03-10MNOV0.006.060.65
2025-03-11MNOV0.006.060.65
2025-03-12MNOV0.006.060.59
2025-03-13MNOV0.006.060.59
2025-03-14MNOV0.006.060.59
2025-03-17MNOV0.006.100.59
2025-03-18MNOV0.006.100.59
2025-03-19MNOV0.006.100.59
2025-03-20MNOV0.006.100.59
2025-03-21MNOV0.006.100.59
2025-03-24MNOV0.006.210.59
2025-03-25MNOV0.006.210.59
2025-03-26MNOV0.006.210.52
2025-03-27MNOV0.006.210.52
2025-03-28MNOV0.006.210.52
2025-03-31MNOV0.006.210.52
2025-04-01MNOV0.006.210.52
2025-04-02MNOV0.006.210.52
2025-04-03MNOV0.006.210.52
2025-04-04MNOV0.006.210.52
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
23 items Current Page1 of 1

Last Quarter Act. EPS

-0.06

Avg. EPS Est. Current Quarter

-0.14

Avg. EPS Est. Next Quarter

-0.12

Insider Transactions

Institutional Transactions

6.21

Beta

0.49

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

12

Growth Score

21

Sentiment Score

12

Actual DrawDown %

90.6

Max Drawdown 5-Year %

-89.7

Target Price

7.5

P/E

Forward P/E

PEG

P/S

P/B

1.16

P/Free Cash Flow

EPS

-0.23

Average EPS Est. Cur. Y​

-0.5

EPS Next Y. (Est.)

-0.38

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

2.76

Return on Equity vs Sector %

-40.8

Return on Equity vs Industry %

-27.9

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

MediciNova, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 13
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company develops MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent in Phase 2b/3 clinical trial for treating neurological and other disorders, such as progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and substance dependence and addiction, as well as prevention of acute respiratory distress syndrome, and long COVID. It is also developing MN-001 (tipelukast), an orally bioavailable small molecule compound in Phase 2 clinical trial to treat fibrotic and other metabolic disorders, including nonalcoholic fatty liver disease and hypertriglycedemia. The company has a license agreement with Kyorin Pharmaceuticals for the development and commercialization of MN-166 and MN-001. MediciNova, Inc. was incorporated in 2000 and is headquartered in La Jolla, California.
stock quote shares MNOV – Medicinova Inc Stock Price stock today
news today MNOV – Medicinova Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch MNOV – Medicinova Inc yahoo finance google finance
stock history MNOV – Medicinova Inc invest stock market
stock prices MNOV premarket after hours
ticker MNOV fair value insiders trading